Pillar Biosciences Achieves Nationwide Medicare Coverage for Innovative oncoReveal® CDx Pan-Cancer Testing Pillar Biosciences, a leader in Decision Medicine™, announces receipt of CMS coverage for its FDA-approved oncoReveal® CDx kit, enhancing access for cancer patients.

Pillar Biosciences Achieves Nationwide Medicare Coverage for Innovative oncoReveal® CDx Pan-Cancer Testing #USA #Natick #Pillar_Biosciences #oncoReveal #Decision_Medicine